|
Volumn 98, Issue 1, 2001, Pages 119-124
|
Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
GELATINASE A;
INTEGRIN;
TSR 1265;
UNCLASSIFIED DRUG;
VITRONECTIN;
ANGIOGENESIS;
ANIMAL TISSUE;
ARTICLE;
CANCER INHIBITION;
CANCER INVASION;
CELL ADHESION;
CONTROLLED STUDY;
DRUG MECHANISM;
EMBRYO;
ENDOTHELIUM CELL;
ENZYME ACTIVATION;
IN VIVO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
CHICK EMBRYO;
CHORION;
COLLAGEN;
CRICETINAE;
ENDOTHELIUM, VASCULAR;
ENZYME ACTIVATION;
HISTOCYTOCHEMISTRY;
IMMUNOBLOTTING;
MATRIX METALLOPROTEINASE 2;
MELANOMA;
NEOPLASM TRANSPLANTATION;
NEOVASCULARIZATION, PATHOLOGIC;
OLIGOPEPTIDES;
PROTEIN BINDING;
RECEPTORS, VITRONECTIN;
TUMOR CELLS, CULTURED;
VITRONECTIN;
ANIMALIA;
|
EID: 0035793037
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.011343298 Document Type: Article |
Times cited : (288)
|
References (22)
|